This website is intended for healthcare professionals only and contains promotional content.

Report an adverse event here
Link Logo

NOTICE: Kyowa Kirin International has agreed a joint venture with Grünenthal GmbH for the Established Medicines portfolio. The new company, KKI NewCo (known as Grünenthal Meds), is responsible for the content on this page. For more information please click here.​

Oncology

Breakthrough Cancer Pain (BTcP)

Transient exacerbations of pain, known as BTcP, are a common problem in cancer patients, as a direct or indirect result of the cancer itself, or the cancer treatment.1

Chemotherapy-induced Nausea and Vomiting (CINV)

Chemotherapy-induced nausea and vomiting (CINV) is one of the most distressing and acute side effects of cancer treatment. It can have a significant impact on a patient’s quality of life.2

Find out more information about
Grünenthal Meds products.

LEARN MORE

Average:

  • References

    1. Davies AN et al. BMJ Support Palliative Care 2018;0:1-9. Doi:10.1136/bmjspcare-2017-001467.

    2. National Cancer Institute. Nausea and Vomiting Related to Cancer Treatment. Available at: https://www.cancer.gov/about-cancer/treatment/side-effects/nausea/nausea-hp-pdq/ [Last accessed: March 2022].

    KKI/INT/KKI/0599 November 2023